![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 30, 2022 6:00:58 PM
While the patents I have worked on are all related to computer systems, I feel pretty confident in stating that BrainWise would not qualify for a patent with USPTO - a 'unique formulation' of common ingredients generally doesn't get there.
It looks like the Mark application failed because the company was unable to demonstrate use in the marketplace. Given that they only announced their distribution partnership a few months ago, it's not surprising that they couldn't demonstrate use of the Mark (the tweets/PRs probably aren't sufficient).
It's possible that they could revive the filing for the Mark, although the fact that it's been used in trade for awhile (albeit for what I assume is the same product) may impact the outcome.
Recent SHMN News
- Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor • AllPennyStocks.com • 06/10/2024 06:30:00 PM
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM